A new trading day began on Monday, with Cellectar Biosciences Inc (NASDAQ: CLRB) stock price up 6.72% from the previous day of trading, before settling in for the closing price of $0.32. CLRB’s price has ranged from $0.22 to $4.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 47.54%. With a float of $45.31 million, this company’s outstanding shares have now reached $46.08 million.
The firm has a total of 11 workers. Let’s measure their productivity. In terms of profitability, gross margin is 32.05%, operating margin of -15613.22%, and the pretax margin is -13522.69%.
Cellectar Biosciences Inc (CLRB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cellectar Biosciences Inc is 1.67%, while institutional ownership is 11.18%. The most recent insider transaction that took place on Jan 10 ’25, was worth 8,400. In this transaction Chief Operating Officer of this company bought 30,000 shares at a rate of $0.28, taking the stock ownership to the 83,141 shares.
Cellectar Biosciences Inc (CLRB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.51% during the next five years compared to 40.27% growth over the previous five years of trading.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
Here are Cellectar Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
Analysing the last 5-days average volume posted by the [Cellectar Biosciences Inc, CLRB], we can find that recorded value of 3.37 million was better than the volume posted last year of 1.86 million. As of the previous 9 days, the stock’s Stochastic %D was 68.76%. Additionally, its Average True Range was 0.03.
During the past 100 days, Cellectar Biosciences Inc’s (CLRB) raw stochastic average was set at 5.71%, which indicates a significant decrease from 93.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.45% in the past 14 days, which was lower than the 239.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2890, while its 200-day Moving Average is $1.5956. Now, the first resistance to watch is $0.3489. This is followed by the second major resistance level at $0.3609. The third major resistance level sits at $0.3804. If the price goes on to break the first support level at $0.3174, it is likely to go to the next support level at $0.2979. Now, if the price goes above the second support level, the third support stands at $0.2859.
Cellectar Biosciences Inc (NASDAQ: CLRB) Key Stats
With a market capitalization of 15.52 million, the company has a total of 46,080K Shares Outstanding. Currently, annual sales are 0 K while annual income is -37,980 K. The company’s previous quarter sales were 0 K while its latest quarter income was -14,660 K.
